[Malignant mesothelioma of the ovary: a case report].

Mésothéliome malin de l´ovaire: à propos d´un cas.

Journal

The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926

Informations de publication

Date de publication:
2021
Historique:
received: 21 06 2020
accepted: 15 01 2021
entrez: 23 4 2021
pubmed: 24 4 2021
medline: 6 5 2021
Statut: epublish

Résumé

Primary malignant mesothelioma of the ovary (PMMO) is an extremely rare tumor which can develop from mesothelial cells. This neoplasia is caused predominantly by exposure to asbestos or other cancer-causing agents. Preoperative assessment, based on computed tomography (CT) scan, magnetic resonance imaging and positron emission tomography, is essential for cancer staging. Anatomopathological diagnosis is based on immunohistochemical findings. PMMO is an exceptional disease involving a multidisciplinary therapeutic strategy including the use of chemotherapy which improves the management and prognosis of patients. This study reports the case of a female patient undergoing suboptimal surgery complemented by adjuvant chemotherapy with complete radiological response and 1-year disease-free survival.

Identifiants

pubmed: 33889258
doi: 10.11604/pamj.2021.38.92.24462
pii: PAMJ-38-92
pmc: PMC8035692
doi:

Types de publication

Case Reports

Langues

fre

Sous-ensembles de citation

IM

Pagination

92

Informations de copyright

Copyright: Imane Ouafki et al.

Déclaration de conflit d'intérêts

Les auteurs ne déclarent aucun conflit d´intérêts.

Références

J Cancer Res Ther. 2015 Jul-Sep;11(3):654
pubmed: 26458642
Am J Surg Pathol. 1996 Sep;20(9):1067-80
pubmed: 8764743
Oncol Lett. 2017 Oct;14(4):4557-4562
pubmed: 29085453
Cancer Med. 2016 May;5(5):950-9
pubmed: 26860323
Am J Surg Pathol. 1995 Oct;19(10):1124-37
pubmed: 7573671
Mol Clin Oncol. 2019 Oct;11(4):397-400
pubmed: 31475068
Int J Surg Pathol. 2010 Jun;18(3 Suppl):178S-180S
pubmed: 20484287
Ann Gastroenterol. 2018 Nov-Dec;31(6):659-669
pubmed: 30386115
Ann Oncol. 2007 Jun;18(6):985-90
pubmed: 17030547

Auteurs

Imane Ouafki (I)

Service d´Oncologie Médicale, Centre Hospitalier Universitaire (CHU) Hassan II, Fès, Maroc.

Lamyae Nouiakh (L)

Service d´Oncologie Médicale, Centre Hospitalier Universitaire (CHU) Hassan II, Fès, Maroc.

Raihana Boujarnija (R)

Service d´Oncologie Médicale, Centre Hospitalier Universitaire (CHU) Hassan II, Fès, Maroc.

Afaf Amarti (A)

Centre d´Anatomo-pathologie Al Azhar, Fès, Maroc.

Lamiae Amaadour (L)

Service d´Oncologie Médicale, Centre Hospitalier Universitaire (CHU) Hassan II, Fès, Maroc.

Karima Oualla (K)

Service d´Oncologie Médicale, Centre Hospitalier Universitaire (CHU) Hassan II, Fès, Maroc.

Zineb Benbrahim (Z)

Service d´Oncologie Médicale, Centre Hospitalier Universitaire (CHU) Hassan II, Fès, Maroc.

Samia Arifi (S)

Service d´Oncologie Médicale, Centre Hospitalier Universitaire (CHU) Hassan II, Fès, Maroc.

Nawfel Mellas (N)

Service d´Oncologie Médicale, Centre Hospitalier Universitaire (CHU) Hassan II, Fès, Maroc.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH